BLC® with Hexvix® allows you to detect bladder cancer missed under White Light Cystoscopy alone1,2,3
Hexvix® is a drug that is taken up by cancer cells in the bladder making them glow bright pink during BLC®.11
Hexvix® detects bladder cancer missed under White Light Cystoscopy alone3,4,5
Hexvix® can
be used during
surgical treatment
and surveillance
/follow-up
In 25%
of patients at least 1
additional lesion was
found with Hexvix®3
Hexvix® detects patients with CIS that would be missed under WLC alone2
Hexvix® TURBT procedures led to reduced recurrence rates versus WLC TURBT alone 3,5,15
![a](/sites/hexvix.productie2.medonline.nl/files/images/2020-01-20_14-54-40.png)
This message is only to be used if specifically requested by the Physician and should not be proactively communicated
- The above is to avoid having Hexvix® niched for use in high-risk patients, when it can benefit intermediate risk patients as well
- Earlier detection will lead to better patient outcomes
Hexvix® led to increased time to recurrence12
Patients remained on average an additional 7 months tumor free when Hexvix® was used versus WLC alone12
Hexvix® can be used during surgical treatment and surveillance/follow-up
Hexvix® guided TURBT demonstrated to be an independent predictor for improved survival after radical cystectomy19
CSS: Cancer Specific Survival; OS: Overall Survival.
Hexvix® should be used for the first TURBT and for all intermediate and high-risk patients, during surgical treatment and surveillance/follow-up7,8,9
How is Hexvix® used
Recommended use cases7,8,9
*primarily for referred patients
**consensus on frequency was not reached